Devices placed on the EU market before 28 May 2026 and still sold after that date must be registered in the Eudamed UDI/Device module by 28 November 2026. For manufacturers who provide instructions for use in electronic form, the registration has one field that did not exist as an obligation before July 2025: the internet address of the eIFU. This post explains where that obligation comes from, what the address has to be, and what to check in the next twelve days.

Cover: Eudamed, 28 November 2026 and the eIFU address in your UDI record, with the five properties the address must have

Where the obligation comes from

Commission Decision (EU) 2025/2371, published in the Official Journal on 27 November 2025, declared four Eudamed modules functional: Actor registration, UDI/Device registration, Notified Bodies and Certificates, and Market Surveillance. Their use became mandatory six months later, on 28 May 2026. Devices already on the market before that date have until 28 November 2026 to be registered in the UDI/Device module [1].

Separately, Commission Implementing Regulation (EU) 2025/1234 added a paragraph 3 to Article 7 of the eIFU implementing regulation (EU) 2021/2226: manufacturers providing eIFU shall submit the internet address of the electronic instructions to the UDI database, in line with Annex VI, Part B, point 22 of the MDR, from the date device registration applies under Article 123(3)(d) and (e) of the MDR [2]. That date has now arrived.

The two deadlines therefore meet: a legacy device registered by 28 November 2026 that is supplied with eIFU needs its eIFU address in the record.

What the address has to be

Article 7(2) of Regulation 2021/2226 sets the properties of the address and of the site behind it [3]:

  • It must be stable and directly accessible for the retention period: 10 years after the last device is placed on the market, or 15 years for implantables and devices without an expiry date.
  • The site must be protected against intrusion and tampering, designed to minimise downtime and display errors, and compliant with the GDPR.
  • Documents must be in a commonly used format readable with freely available software.
  • All previous versions must be kept available with their publication dates.

A URL on the corporate website that depends on a content management system, a marketing agency or a domain renewal is a risk against every one of these. A deep link that changes with the next redesign is a non-conformity waiting for the next audit.

Twelve-day checklist

  1. List every device registered or to be registered in Eudamed that is supplied with eIFU.
  2. For each, confirm the eIFU address you will submit resolves to the current version and to the version history, without login.
  3. Check that the address is at product level (UDI-DI or product family), not a generic home page, so the UDI record points to the right instructions.
  4. Confirm who owns the domain and the hosting, and that both are secured for at least 15 years.
  5. Record the address in your technical documentation and in the label artwork (Article 6 requires the label to state how to access the eIFU).
  6. If the device is also sold in Switzerland, note that Swissmedic applies the same obligation [4].
  7. Submit the registration before 28 November 2026.

Which devices may be supplied with eIFU at all, in the EU and in the other major markets, is covered in our market-by-market review of the legal status of eIFU [5].

If the address is the problem

Many manufacturers are discovering that they have an eIFU, but not an eIFU address they are willing to commit to for 15 years. That is the gap eLeaflet™ by myHealthbox closes: every product published on eifu.me gets a stable, product-level URL on the global eIFU search engine and, if you want it, on your own yourcompany.eifu.me site, with full version history, no login, and infrastructure validated against EU GMP Annex 11 and FDA 21 CFR Part 11. We can load a product range in days. Request a demo if 28 November is close.

References

  1. Commission Decision (EU) 2025/2371 of 26 November 2025 on the functionality of certain Eudamed electronic systems. https://eur-lex.europa.eu/eli/dec/2025/2371/oj
  2. Commission Implementing Regulation (EU) 2025/1234, Article 1 (new Article 7(3) of Regulation 2021/2226). https://eur-lex.europa.eu/eli/reg_impl/2025/1234/oj/eng
  3. Commission Implementing Regulation (EU) 2021/2226, Articles 5, 6 and 7. https://eur-lex.europa.eu/eli/reg_impl/2021/2226/oj
  4. Swissmedic — implementation of the EU implementing regulation on eIFU, 8 August 2025. https://www.swissmedic.ch/swissmedic/en/home/medical-devices/regulation-of-medical-devices/anwendbare-rechtsakte-gemaess-eu-mdr/umsetzung-eu-durchfuehrungsverordnung-gebrauchsanweisungen.html
  5. Is eIFU legal? The 2026 status of electronic instructions for use, market by market — our market-by-market review. https://blog.eleaflet.eu/en/eifu-legal-status-2026

This article is a regulatory overview for information purposes, current as of 16 November 2026. It is not legal advice. Check the official texts, which are linked above, before taking a product decision.

Related Posts



Article précédent